Fig. 2From: Enterolactone has stronger effects than enterodiol on ovarian cancerViability inhibition of ES-2 cells by END and ENL revealed by Trypan blue assays. a Cell viability (%) after END treatment. b Cell viability (%) after ENL treatment. Results were obtained from three independent experiments. *PÂ <Â 0.05, compared with the controlBack to article page